one of the mabs , dg2 , was identified as a bfgf neutralizing antibody on the basis of its ability to inhibit , in vitro , the binding of [ 125i ] -bfgf to high and low affinity bfgf sites on cultured baby hamster kidney cells and bfgf-induced [ 3h ] -thymidine incorporation in cultured 3t3 cells , and in vivo , the angiogenic response to bfgf in a rat kidney capsule model of angiogenesis .
C0022646
kidney
C0227616
kidney capsule